Skip to content

ZURA - Zura Bio Ltd - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchZ

Zura Bio Limited Class A Ordinary Shares

ZURA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

Z

ZURAZura Bio Limited Class A Ordinary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $7.44
52-wk low: $1.88
Prev close: $4.90
Mkt cap: $559.6M
Beta: -0.03
P/B: 2.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$63.3M

QR
Qube Research
Q1 2026 13F
$2.7M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 5.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $560M

Valuation

P/B2.80

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ZURA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $559.64M
Beta: -0.03

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-51.0%

$2.1M

position

JS

Jim Simons

Q2 2026 13F

$1.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ZURA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.21-5.0%

-$0.20 expected

Next report

What the street expects next

EPS expected

-$0.19

-$0.19 to -$0.18

Revenue expected

$0.00

6 analysts

-51.0%

ROA-31.2%

Growth

Beta-0.03